Table 1.

Characteristics of 15 patients with colorectal cancer (A) and 10 patients with colorectal liver metastases (B) who received mirtocyan

A.
CharacteristicsValue
Age (y)
    Median64
    Range47-90
Gender
    Female/Male5/10
Body mass index, kg/m2
    Median29
    Range16.7-38.6
ASA grade
    13
    29
    33
    4/50
Drug history
    Aspirin2
    Antihypertensives7
    Antianginals0
    Analgesics (non-NSAID)2
    Neoadjuvant therapy0
Tumor location*
    Caecum/ascending colon7
    Transverse colon1
    Descending colon1
    Sigmoid colon6
    Rectum1
Tumor differentiation*
    Well0
    Moderate15
    Poor1
Dukes stage of tumor*
    A0
    B9
    C17
    C2/D0
B.
CharacteristicsValue
Age, y
    Median66
    Range50-76
Gender
    Female/Male2/8
Body mass index, kg/m2
    Median29
    Range24-34
ASA grade
    13
    22
    35
    4/50
Drug history
    Aspirin1
    Antihypertensives3
    Antianginals0
    Analgesics (non-NSAID)1
Neoadjuvant therapy
    Radiotherapy0
    Chemotherapy8
Tumor location
    Right lobe2
    Left lobe2
    Bilobar6
No. of metastases
    12
    23
    3/40
    5 or more5
Original bowel resection
    Right hemicolectomy5
    Sigmoid colectomy1
    Anterior resection4
Time from bowel resection to liver resection (mo)
    Median9.5
    Range6-70

Abbreviation: NSAID, non-steroidal anti-inflammatory drug.

  • *A total of 16 adenocarcinomas were identified in colorectal resection specimens.